VOYA INVESTMENT MANAGEMENT LLC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1068837 ATLANTA, GA

Position in FULC

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$45,182

-$31,702 QoQ

Shares Held

12,345

+23.2% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#112

of 154 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. FULC ranks #184 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	505,219	$250,957,432
2	PTGX	Protagonist Therapeutics, Inc	571,618	$70,068,932
3	SRRK	Scholar Rock Holding Corp	890,607	$48,983,385
4	KRYS	Krystal Biotech, Inc.	124,442	$46,251,357
5	TGTX	Tg Therapeutics, Inc.	819,253	$45,009,759
6	PTCT	Ptc Therapeutics, Inc.	539,319	$43,992,249
7	PRAX	Praxis Precision Medicines, Inc.	122,227	$40,920,376
8	REGN	Regeneron Pharmaceuticals, Inc.	65,505	$40,844,986

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$45,182	12,345	+23.2%	Shares	Defined	2026-08-12
2026-03-31	$76,884	10,024	-35.0%	Shares	Defined	2026-05-12
2025-06-30	$106,027	15,411	-16.9%	Shares	Defined	2025-08-14
2025-03-31	$53,418	18,548	-6.7%	Shares	Defined	2025-06-18
2024-12-31	$93,473	19,888	-8.2%	Shares	Defined	2025-05-02
2024-09-30	$77,365	21,671	+2.4%	Shares	Defined	2025-02-07
2024-06-30	$131,154	21,154	-51.1%	Shares	Defined	2025-02-07
2023-03-31	$123,365	43,286	+222.7%	Shares	Defined	2025-02-07
2022-06-30	$65,723	13,413	+17.9%	Shares	Defined	2022-08-15
2022-03-31	$269,089	11,378	+12.9%	Shares	Defined	2022-05-16
2021-12-31	$178,332	10,081	-4.5%	Shares	Defined	2022-02-14
2021-09-30	$297,643	10,551	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.